Literature DB >> 22414711

Blood utilization: fostering an effective hospital transfusion culture.

Carolyn Hyatt Sherman1, Duncan C Macivor.   

Abstract

An effective hospital transfusion culture should encourage clinicians to consider the possibility of transfusion in their patients well before the need actually arises, and to plan ahead in an attempt to use blood products most efficiently. Strategies for improved blood utilization include timely and adequate preoperative assessment of risk, optimization of baseline hemoglobin, anticipation of potential transfusion problems, intraoperative techniques to minimize blood loss, blood conservation technologies, transfusion guidelines and targeted therapy, point of care testing, and massive transfusion protocols. Attention to these elements promotes a safe and cost-effective transfusion culture. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22414711     DOI: 10.1016/j.jclinane.2011.06.020

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  4 in total

1.  Blood Transfusion Policies in Elective General Surgery: How to Optimise Cross-Match-to-Transfusion Ratios.

Authors:  Thomas C Hall; Clare Pattenden; Chloe Hollobone; Cristina Pollard; Ashley R Dennison
Journal:  Transfus Med Hemother       Date:  2013-01-03       Impact factor: 3.747

Review 2.  Perioperative blood management.

Authors:  M Manjuladevi; Ks Vasudeva Upadhyaya
Journal:  Indian J Anaesth       Date:  2014-09

3.  An Analysis of Blood Utilization for Stem Cell Transplant Patients in a Tertiary Care Hospital.

Authors:  Natasha Ali
Journal:  Int J Stem Cells       Date:  2017-05-30       Impact factor: 2.500

4.  Evaluation of a novel Cardiac Peri-Operative Transfusion Trigger Scoring system in patients with coronary artery disease.

Authors:  Hai-Ping Ma; Lei Zhang; Chun-Ling Chen; Jin Li; Zhi Tong Ma; Qiao Qiao Jiang; Yuan Yuan Liang; Shan Shan Li; Fei Long; Hong Zheng
Journal:  BMC Cardiovasc Disord       Date:  2021-01-19       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.